Amneal Pharmaceuticals, Inc. Class A Common Stock
AMRX Real Time Price USDRecent trades of AMRX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AMRX's directors and management
Government lobbying spending instances
-
$910,000 Apr 21, 2025 Issue: Health Issues
-
$210,000 Jan 21, 2025 Issue: Health Issues
-
$230,000 Jan 21, 2025 Issue: Health Issues
-
$240,000 Jan 21, 2025 Issue: Health Issues
-
$850,000 Jan 21, 2025 Issue: Health Issues
-
$40,000 Apr 20, 2022 Issue: Pharmacy
-
$60,000 Jan 20, 2022 Issue: Pharmacy
-
$60,000 Oct 20, 2021 Issue: Pharmacy
-
$60,000 Jul 20, 2021 Issue: Pharmacy
-
$60,000 Apr 20, 2021 Issue: Pharmacy
-
$60,000 Jan 21, 2021 Issue: Pharmacy
-
$60,000 Oct 20, 2020 Issue: Pharmacy
-
$50,000 Jul 20, 2020 Issue: Pharmacy
-
$20,000 Feb 01, 2019 Issue: None
-
$20,000 Jan 18, 2019 Issue: None
-
$20,000 Oct 08, 2018 Issue: None
-
$20,000 Jul 12, 2018 Issue: None
-
$40,000 Apr 16, 2018 Issue: Health Issues Budget/Appropriations
-
$40,000 Jan 20, 2018 Issue: Trade (domestic/foreign) Health Issues
-
$40,000 Dec 28, 2017 Issue: Health Issues
-
$40,000 Oct 19, 2017 Issue: Health Issues
-
$40,000 Jul 19, 2017 Issue: Health Issues
-
$40,000 Apr 20, 2017 Issue: Health Issues
-
$40,000 Oct 20, 2016 Issue: Pharmacy Health Issues
-
$40,000 Jul 19, 2016 Issue: Health Issues Pharmacy
-
$40,000 Apr 14, 2016 Issue: Pharmacy Health Issues
-
$40,000 Jan 15, 2016 Issue: Pharmacy Budget/Appropriations Copyright/Patent/Trademark Health Issues
-
$40,000 Oct 19, 2015 Issue: Pharmacy Health Issues Copyright/Patent/Trademark
-
$40,000 Jul 14, 2015 Issue: Pharmacy Health Issues Budget/Appropriations
-
$10,000 Apr 17, 2015 Issue: Health Issues Medicare/Medicaid Budget/Appropriations Pharmacy
-
$40,000 Apr 17, 2015 Issue: Health Issues Budget/Appropriations Pharmacy
-
$30,000 Jan 20, 2015 Issue: Pharmacy
-
$20,000 Jan 18, 2015 Issue: Insurance Health Issues Taxation/Internal Revenue Code Medicare/Medicaid Budget/Appropriations Pharmacy
-
$10,000 Oct 18, 2014 Issue: Pharmacy Taxation/Internal Revenue Code Health Issues Budget/Appropriations Insurance Food Industry (safety, labeling, etc.) Medicare/Medicaid
-
$30,000 Oct 15, 2014 Issue: Pharmacy
-
$30,000 Jul 18, 2014 Issue: Pharmacy Health Issues Budget/Appropriations
-
$30,000 Apr 16, 2014 Issue: Pharmacy Health Issues Budget/Appropriations
-
$25,000 Jan 16, 2014 Issue: Budget/Appropriations Health Issues Pharmacy
Estimated quarterly lobbying spending
AMRX Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to AMRX
Recent picks made for AMRX stock on CNBC
ETFs with the largest estimated holdings in AMRX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $AMRX stock a Buy, Sell, or Hold?
- What is the price target for $AMRX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $AMRX stock?
- Who owns the most shares of $AMRX stock?
- What funds own $AMRX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AMRX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.